Epigenetics is the branch of science which involves the study of heritable changes in the gene function without any mutation of the DNA. Epigenetics has the ability to influence DNA transcription and translation. The epigenetics application and end-user base is expanding with the rising number of scientific discoveries. This factor is propelling the growth of the epigenetics market globally.
According to the National Cancer Institute, cancer is among the leading causes of death worldwide, for which as per a recent study, epigenetic inhibitors consist of the characteristics and functions which have the potential in cancer prevention and control. This factor has provided an impetus to the research conducted on epigenetics in the oncology industry.
In the forecasted period between 2010 to 2020 the epigenetics market is expected to remain aggressive as the number of new entrants in this market will keep rising with the constant advent of new technologies coupled with enhanced features. On the global frontier, North America is projected to hold a major share of the market revenue followed by the emerging markets of the APAC region.
A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Epigenetics Market and future opportunities are provided in the report. This report on the Global Epigenetics Market identifies many such insights and M&A opportunities, besides providing a detailed analysis of the Epigenetics market.
Sample Companies Profiled in this Report are:
- Illumina Inc.
- Abcam plc.
- New England Biolabs
- Diagenode s.a.
1. Epigenetics Market- Market Overview
2. Executive Summary
3. Epigenetics Market - Market Landscape
3.1. Market Share Analysis
3.2. Comparative Analysis
3.2.1. Product Benchmarking
3.2.2. End user profiling
3.2.3. Patent Analysis
3.2.4. Top 5 Financials Analysis
4. Epigenetics Market - Market Forces
4.1. Market Drivers
4.2. Market Constraints
4.3. Market Challenges
4.4. Attractiveness of the Aircraft Lighting Systems Industry
4.4.1. Power of Suppliers
4.4.2. Power of Customers
4.4.3. Threat of New entrants
4.4.4. Threat of Substitution
4.4.5. Degree of Competition
5. Epigenetics Market – Strategic Analysis
5.1. Value Chain Analysis
5.2. Pricing Analysis
5.3. Opportunities Analysis
5.4. Product/Market Life Cycle Analysis
5.5. Suppliers and Distributors
6. Epigenetics Market - By Products
6.1.1. Bisulfite Conversion Kit
6.1.2. Chromatin Immunoprecipitation Seq (ChIP) Kit
6.1.3. Histone Purification Kit
6.1.4. RNA sequencing Kit
126.96.36.199. DNA Polymerases
6.4.1. Next-generation Sequencers
6.4.2. Mass Spectrometers
7. Epigenetics Market - By Application
7.1.1. Cancer Therapy
188.8.131.52. Breast Cancer
184.108.40.206. Lung Cancer
220.127.116.11. Colon Cancer
7.3. Developmental Biology
8. Epigenetics Market - By End Users
8.1. Research Institutes
8.2. Diagnostic Centres
9. Epigenetics Market - By Geography
9.1. North America
9.2. South America
9.5. Middle East & Africa
10. Market Entropy
10.1. New Product Launches
10.2. M&As, Collaborations, JVs, Partnership
11. Company Profiles (Overviews, Financials, Product Portfolio, Developments, SWOT Analysis).
11.1. Thermo Fischer Scientific
11.2. Active Motif
11.3. Illumina Inc.
11.4. Abcam plc.
11.5. New England Biolabs
11.6. Diagenode s.a.
11.9. Zymo Research Corporation
11.10. Pfizer Inc.
11.11. Almac group Ltd.
11.13. Zenith Epigenetics Corp.
11.15. Epigentek Group Inc.
11.16. Promega Corporation
*More than 30 Companies are profiled in this Research Report, Complete List available on Request*
"*Financials would be provided on a best efforts basis for private companies"
12.3. Research Methodology
12.5. Compilation of Expert Insights